Navigation Links
Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway

d other biological pathways, as well as for the development of new therapeutic candidates such as nab-docetaxel (ABI-008) and the HSP90 inhibitor nab-17-AAG (ABI 010), among others.

About nab(TM) Technology Platform

Developed by Abraxis BioScience, nanoparticle albumin-bound (nab(TM)) tumor-targeting technology harnesses the unique natural properties of the human protein albumin, to transport and deliver therapeutic agents to the site of disease. The binding of albumin to the anticancer agent creates nanometer-sized particles, which are approximately 1/100th the size of a single red blood cell. These nab particles are readily incorporated into the body's own transport processes and are able to exploit the tumors' attraction to albumin, enabling the delivery of higher concentrations of the active drug to the target site. This may lead to an increase in the drug's antitumor effect and the potential for an effective response. In addition, nab technology offers the ability to improve a drug's solubility by avoiding the need for toxic chemicals, such as solvents, in the administration process, thus potentially improving safety through the elimination of solvent-related side effects.

Abraxis BioScience received approval from the U.S. Food and Drug Administration for ABRAXANE(R) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease in 2005, its first product developed using the nab technology. Studies are ongoing to evaluate several other therapeutic candidates that employ the nab technology including nab-docetaxel (ABI-008), nab-rapamycin mTOR inhibitor (ABI 009), and nab-17AAG HSP90 inhibitor (ABI 010), among others.

About Abraxis BioScience, Inc.

Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
2. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation

Post Your Comments:
(Date:11/6/2009)...6 Philips Respironics applauds the...evention (CDC) to raise awareness about an importa...ncy. The CDC,s release of the first-ever governmen...leeplessness is a milestone in quantifying the siz...educator, industry leader and sleep therapy manufa...
(Date:11/6/2009)... N.C., Nov. 6 Chimerix, Inc., a bi... antiviral therapeutics to address life-threatenin...f the company,s lead antiviral compound, CMX001, t...al Health Security Initiative (GHSI). CMX001 is a...r the treatment of smallpox, as well as other seri...
(Date:11/6/2009)...wire-FirstCall/ -- Caraco Pharmaceutical Laborator...c tromethamine ophthalmic solution, 0.5% following...stration (FDA) for Sun Pharma,s Abbreviated New Dr...halmic solution on the first day following patent ...tically equivalent to Acular® Ophthalmic Solu...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2NHIT Processes Over 4 000 Production Transactions Advances Adoption of NHIN Initiative 58809 1NHIT Processes Over 4 000 Production Transactions Advances Adoption of NHIN Initiative 58809 2Cancer Survivors Share The Day I Found Out 28TM 29 58807 1Cancer Survivors Share The Day I Found Out 28TM 29 58807 2You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 1You Can Thrive 21 Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 58805 2
...irst Presentation of Full Data Set from the TRIUMP...Treprostinil, SILVER SPRING, Md., May 21 United,...wholly-owned subsidiary,Lung Rx, Inc. today announ...the treatment of pulmonary arterial hypertension (...an Thoracic Society (ATS) meeting in Toronto,Ontar...
...OHANNESBURG, South Africa, May 21 BARC, a global,...ing agreement to support,HIV vaccine trials curren...cine Trials Network (HVTN)., The HVTN vaccine tri...at will advance knowledge and ultimately lead to a...on. The HVTN is supported through a,cooperative ag...
Other Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 2BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials 3
(Date:11/8/2009)...,, Higher Costs and Crushing Taxes Nail Nation,...e-USNewswire/ -- In response to U.S. House passage...ss & Entrepreneurship Council (SBE Council) pr...ing statement: ,, "Make no mistake, those voti...creators with higher costs and crushing taxes and ...
(Date:11/8/2009)... Freeze-drying of biophar... Mississauga, Ontario facility. , ...Thomas Wellner, President and CEO of Therapure Bio...aken delivery of a commercial scale pharmaceutical... scale freeze drying (lyophilization) available fo...
(Date:11/8/2009)...,, Nation,s largest network of Hispanic health...h care reform in 2009 ,, WASHINGTON, Nov. 7 /P...f Representatives showed they have heard the voice...ealth Care for America Act. Now the Senate must de... health care reform," said Dr. Jane L. Delgado, Pr...
(Date:11/8/2009)...,, AARP Praises House Passage of Health Care R...ngthen Medicare, improve coverage for all American...- Today, the United States House of Representative...e reform legislation that would strengthen Medicar...companies that prices millions of Americans out of...
(Date:11/7/2009)...,, WASHINGTON , Nov. 7 /PRNewswire-USNewswire...r today in support of H.R. 3962, the Affordable He... the legislation later tonight. Below are the Spe...e all know, is an historic moment for our nation a...eaders of every party and political philosophy -- ...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...dical Small Businesses Will Be Closed Because of M... The American Association for Homecare applauds P...businesses by providing $15 billion in loans to lo...ome medical equipment (HME) sector by rescinding t...
...University and the Georgia Institute of Technology...chers around Atlanta with a dedicated magnetic res...ysteries of the brain and mind. , The Center for ... disabilities, to applied physiology, brain signal...
... 18 Nuvilex, Inc. (OTC Bulletin Board: NVLX), fo...Company,s Spring Break marketing initiatives desig...oducts, InfinitInk and Last Shot Hangover Remedy, ...ms will be combing the beaches, bars and parties o...
... provider ICW celebrates its opening in Canada , ...18 Newt Gingrich, Founder of the Center for Healt...use, along with Frank McKenna, Deputy Chair of TD ...aunch of ICW,s operations in Canada at a luncheon ...
...ws Cesarean deliveries hitting new highs , ...ber of unmarried women who are having babies has r...sarean delivery rates continue to hit new highs, a... from 2006 to 2007. The estimated 1,714,643 babies...
...18 Imaginis.com today announced that it has again... quality from the Health Information Resource Cent...e in providing online patient education informatio...es the best health information Web sites for consu...
Other Medicine News:Health News:American Association for Homecare Applauds President Obama's Plan to Aid Small Businesses 2Health News:American Association for Homecare Applauds President Obama's Plan to Aid Small Businesses 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group 2Health News:Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group 3Health News:Gingrich and McKenna to Speak on Transformation of Healthcare Delivery at ICW Launch 2Health News:Unmarried Childbirths in U.S. Reach Record Levels 2
Protein G, Gold Ribbon - .50 OD per sq. cm.
Protein G, Gold Ribbon - .25 OD per sq. cm.
Protein G, Gold Ribbon - .13 OD per sq. cm.
Naked Gold 80 nm
Medicine Products: